Med24
diabetes 12. 11. 2026 • 2 min read • U.S. Food and Drug Administration (OpenFDA)

Levothyroxine Sodium: FDA Clinical Pharmacology, Indications and Prescribing Update

1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating...

Anemia ja kuolevuus ikääntyvillä – PolSenior-tutkimuksen kuva.

Levothyroxine sodium tablets are indicated for replacement therapy in adult and pediatric patients with hypothyroidism, including congenital or acquired forms. It is also indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. The mechanism of action involves the hormone’s control of DNA transcription and protein synthesis, with triiodothyronine (T3) predominantly derived from L-thyroxine (T4) through deiodination.

Pharmacokinetic Properties

Oral levothyroxine sodium is a synthetic T4 hormone that maintains normal T4 levels when a deficiency is present. Absorption ranges from 40% to 80%, influenced by factors like fasting, malabsorption syndromes, and dietary fiber. Pharmacokinetics demonstrate that circulating thyroid hormones are primarily bound to plasma proteins, with T4 exhibiting higher serum levels and a longer half-life. Distribution is greater than 99% bound to TBG, TBPA, and albumin.

Sponsored content

Metabolic Elimination

Elimination primarily occurs through metabolism, with approximately 80% of T4 being deiodinated to T3 and reverse T3. This process occurs predominantly in the liver, with secondary sites including the kidney. The major pathway involves sequential deiodination, followed by conjugation with glucuronides and sulfates, and excretion via bile and enterohepatic recirculation. Dosage is typically once daily on an empty stomach, at least 4 hours before interfering drugs. Starting doses vary based on patient factors, and therapeutic effect may take 4-6 weeks to achieve. Monitoring of TSH and/or T4 levels, along with clinical status, is essential for adequacy of therapy. Patients should avoid biotin supplements during TSH/T4 assessment.

Original Scientific Source
U.S. Food and Drug Administration (OpenFDA)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement